Increased expression of survivin in gastric cancer patients and in first degree relatives

Survivin was recently described as an apoptosis inhibitor. Its pathogenic role in gastric cancer is largely unknown. Expression of survivin in gastric cancer and non-cancer first-degree relatives, and its association with apoptosis and cyclo-oxygenase-2 expression was investigated. Fifty gastric can...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, J, Leung, W K, Ebert, M P A, Ng, E K W, Go, M Y Y, Wang, H B, Chung, S C S, Malfertheiner, P, Sung, J J Y
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Molecular and Cellular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364284/
https://www.ncbi.nlm.nih.gov/pubmed/12085263
http://dx.doi.org/10.1038/sj.bjc.6600421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364284/
https://www.ncbi.nlm.nih.gov/pubmed/12085263
http://dx.doi.org/10.1038/sj.bjc.6600421

Ejemplares similares